1. Home
  2. NSTS vs BDSX Comparison

NSTS vs BDSX Comparison

Compare NSTS & BDSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NSTS Bancorp Inc.

NSTS

NSTS Bancorp Inc.

HOLD

Current Price

$12.25

Market Cap

60.2M

Sector

Finance

ML Signal

HOLD

Logo Biodesix Inc.

BDSX

Biodesix Inc.

BUY

Current Price

$15.75

Market Cap

122.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
NSTS
BDSX
Founded
1921
2005
Country
United States
United States
Employees
N/A
273
Industry
Savings Institutions
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
60.2M
122.0M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
NSTS
BDSX
Price
$12.25
$15.75
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$32.50
AVG Volume (30 Days)
1.8K
122.8K
Earning Date
01-01-0001
05-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$256,000.00
$88,499,000.00
Revenue This Year
N/A
$22.01
Revenue Next Year
N/A
$26.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
24.08
52 Week Low
$10.73
$0.25
52 Week High
$13.06
$17.40

Technical Indicators

Market Signals
Indicator
NSTS
BDSX
Relative Strength Index (RSI) 50.68 75.40
Support Level $11.91 $6.33
Resistance Level $12.74 N/A
Average True Range (ATR) 0.20 1.66
MACD -0.00 0.29
Stochastic Oscillator 38.60 75.30

Price Performance

Historical Comparison
NSTS
BDSX

About NSTS NSTS Bancorp Inc.

NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

Share on Social Networks: